“versant-ventures” Archives

Entry Author Date Location
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Inception 4 Lands $10,000,000 Series A Funding Round 12/13/13 San Diego
Veracyte, Thyroid Cancer Diagnostic Player, Pulls Off IPO 10/30/13 San Francisco
Immune Design Garners $49,000,000 Series C Financing 10/30/13 Seattle
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Audentes Therapeutics Obtains $30,000,000 Series A Funding Round 07/19/13 San Francisco
Ceterix Comes Out With Tool to Repair, Not Remove, Knee Cartilage 07/16/13 San Francisco
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
VeraCyte Secures $28,000,000 Series C Financing Round 06/28/13 San Francisco
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
ForSight VISION5 Lands $9,300,000 Series B Financing 06/18/13 San Francisco
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
San Diego Life Sciences Roundup: Receptos IPO, Isis, Versant, & More 04/12/13 San Diego
Live! Anderson & Ferrara Headline Rock Stars of Innovation Summit 03/26/13 San Diego
Novira Therapeutics Garners $7,500,000 Series A Funding Round 03/26/13 San Diego
Theraclone Sciences Receives $14,000,000 Series B Funding Round 03/25/13 Seattle
Theraclone Sciences Garners $14,000,000 Series B Financing 03/25/13 Seattle
Holaira Obtains $10,000,000 Series C Financing 02/11/13 Detroit Ann Arbor
Glaukos Obtains $30,000,000 Series F Funding 02/08/13 San Diego
Ocular Therapeutix Secures $23,800,000 Series D Round 01/28/13 Boston
Ceterix Orthopaedics Lands $19,500,000 Series B Round 01/22/13 San Francisco
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
CardiAQ Valve Technologies Secures $37,300,000 Series B Funding 11/29/12 San Diego
San Diego Life Sciences Roundup: Allergan, Qualcomm Life, & More 11/21/12 San Diego
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
Page 2 of 8 « previous page · next page »